| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
International Stem Cell Corporation (OTCQX: ISCO)
ISCO Technical Analysis
5
| As on 12th Nov 2024 ISCO STOCK Price closed @ 0.06 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Strong Sell for SHORT-TERM with Stoploss of 0.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ISCOSTOCK Price
| Open | 0.08 | Change | Price | % |
| High | 0.08 | 1 Day | -0.02 | -25.00 |
| Low | 0.06 | 1 Week | -0.02 | -25.00 |
| Close | 0.06 | 1 Month | -0.03 | -33.33 |
| Volume | 1100 | 1 Year | -0.09 | -60.00 |
| 52 Week High 0.17 | 52 Week Low 0.05 | ||||
OTCQX USA Most Active Stocks
| KRRGF | 4.83 | 2.33% |
| FCUUF | 0.52 | -20.00% |
| FNGR | 1.07 | -46.50% |
| GBTC | 76.47 | 0.20% |
| ETHE | 32.63 | 1.21% |
| ZNOG | 0.07 | 0.00% |
| CURLF | 2.04 | 22.89% |
| VRNOF | 1.90 | 24.18% |
| AOTVF | 0.14 | -6.67% |
| CRLBF | 1.26 | 21.15% |
OTCQX USA Top Gainers Stocks
OTCQX USA Top Losers Stocks
| ISCO Daily Charts |
ISCO Intraday Charts |
Whats New @ Bazaartrend |
ISCO Free Analysis |
|
|
ISCO Important Levels Intraday
| RESISTANCE | 0.10 |
| RESISTANCE | 0.09 |
| RESISTANCE | 0.08 |
| RESISTANCE | 0.07 |
| SUPPORT | 0.05 |
| SUPPORT | 0.04 |
| SUPPORT | 0.03 |
| SUPPORT | 0.02 |
ISCO Forecast December 2024
| 4th UP Forecast | 0.23 |
| 3rd UP Forecast | 0.18 |
| 2nd UP Forecast | 0.14 |
| 1st UP Forecast | 0.11 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.06 |
| 4th DOWN Forecast | -0.11 |
ISCO Weekly Forecast
| 4th UP Forecast | 0.14 |
| 3rd UP Forecast | 0.11 |
| 2nd UP Forecast | 0.10 |
| 1st UP Forecast | 0.08 |
| 1st DOWN Forecast | 0.04 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | -0.02 |
ISCO Forecast2024
| 4th UP Forecast | 0.29 |
| 3rd UP Forecast | 0.22 |
| 2nd UP Forecast | 0.17 |
| 1st UP Forecast | 0.13 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.1 |
| 4th DOWN Forecast | -0.17 |
International Stem Cell Corporation ( OTCQX USA Symbol : ISCO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ISCO Business Profile
International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes. The company also develops, manufactures, and markets skincare products and human cell culture products. Its human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. The company's human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. It sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. The company was incorporated in 2005 and is headquartered in Carlsbad, California. Address: 5950 Priestly Drive, Carlsbad, CA, United States, 92008
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service